This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
com scientificreports | 833 |
creative commons | 557 |
influenza virus | 441 |
respiratory syndrome | 397 |
commons license | 334 |
virus infection | 321 |
acute respiratory | 286 |
scientificreports www | 272 |
amino acid | 254 |
gene expression | 253 |
syndrome coronavirus | 249 |
middle east | 239 |
east respiratory | 230 |
supplementary table | 229 |
epithelial cells | 228 |
performed using | 226 |
doc id | 224 |
rep doi | 224 |
sci rep | 224 |
cord uid | 224 |
viral rna | 192 |
respiratory tract | 176 |
immune response | 173 |
ebola virus | 173 |
competing interests | 173 |
days post | 169 |
present study | 163 |
scientific reports | 162 |
severe acute | 159 |
will need | 154 |
novel coronavirus | 152 |
springer nature | 151 |
infected cells | 151 |
published maps | 150 |
visit http | 150 |
obtain permission | 150 |
third party | 150 |
credit line | 150 |
jurisdictional claims | 150 |
indicated otherwise | 150 |
unless indicated | 150 |
party material | 150 |
nature remains | 150 |
remains neutral | 150 |
institutional affiliations | 150 |
appropriate credit | 145 |
give appropriate | 145 |
previously described | 145 |
statutory regulation | 145 |
permission directly | 145 |
copyright holder | 145 |
original author | 145 |
permits use | 145 |
permitted use | 145 |
intended use | 145 |
authors declare | 144 |
avian influenza | 144 |
intermittent fasting | 140 |
supplementary information | 138 |
infected mice | 138 |
statistically significant | 136 |
immune responses | 132 |
influenza viruses | 128 |
room temperature | 128 |
prostate cancer | 128 |
infectious diseases | 126 |
cell lines | 121 |
plasmodium falciparum | 119 |
international license | 112 |
commons attribution | 112 |
open access | 112 |
amino acids | 111 |
commons licence | 111 |
previous studies | 110 |
nucleic acid | 110 |
innate immune | 109 |
lung injury | 108 |
cell culture | 108 |
united states | 107 |
significantly higher | 105 |
spike protein | 105 |
ms plp | 105 |
flow cytometry | 104 |
coronavirus disease | 104 |
current study | 104 |
viral infection | 104 |
type i | 101 |
virus replication | 101 |
immune system | 99 |
week intermittent | 99 |
described previously | 99 |
mg ml | 98 |
org licenses | 97 |
cell line | 96 |
statistical analysis | 96 |
porcine epidemic | 96 |
negative control | 95 |
risk factors | 94 |
membrane fusion | 94 |
rna viruses | 94 |
western blot | 93 |
time pcr | 92 |
respiratory distress | 92 |
neutralizing antibodies | 92 |
reference genes | 91 |
note springer | 90 |
mg kg | 90 |
viral replication | 88 |
previously reported | 88 |
public health | 88 |
codon optimized | 88 |
zika virus | 87 |
electron microscopy | 87 |
stage hli | 85 |
taken together | 85 |
logistic regression | 84 |
gallic acid | 83 |
distress syndrome | 83 |
monoclonal antibodies | 82 |
protein expression | 81 |
neutrophil elastase | 81 |
clinical signs | 81 |
two groups | 80 |
thermo fisher | 80 |
significant difference | 80 |
reverse transcription | 79 |
wt mice | 78 |
phylogenetic analysis | 78 |
significant differences | 78 |
previous study | 77 |
ag seb | 76 |
escherichia coli | 76 |
control group | 76 |
viral load | 75 |
epidemic diarrhea | 75 |
host cell | 74 |
permissions information | 74 |
com reprints | 74 |
respiratory syncytial | 73 |
results suggest | 73 |
macro domain | 72 |
fisher scientific | 72 |
sample size | 71 |
transmissible gastroenteritis | 71 |
clinical characteristics | 71 |
three times | 71 |
ebov gp | 71 |
monoclonal antibody | 71 |
data analysis | 69 |
inflammatory cytokines | 69 |
syncytial virus | 69 |
goat anti | 69 |
results showed | 68 |
srep sha | 68 |
pr virus | 68 |
neutralizing antibody | 68 |
parainfluenza virus | 67 |
vaccine development | 67 |
mortality rate | 66 |
mechanical ventilation | 66 |
binding site | 66 |
stem cell | 66 |
disease virus | 66 |
data collection | 64 |
mouse model | 63 |
significantly lower | 63 |
positive selection | 63 |
hemorrhagic fever | 63 |
ng ml | 63 |
weight loss | 63 |
informed consent | 63 |
cov infection | 63 |
diarrhea virus | 62 |
coat protein | 62 |
significantly increased | 62 |
rndv expressing | 62 |
virus type | 62 |
dengue virus | 61 |
time points | 61 |
serum samples | 61 |
standard deviation | 61 |
dendritic cells | 61 |
ex vivo | 60 |
crystal structure | 60 |
cancer cells | 59 |
blot analysis | 59 |
systematic review | 59 |
expression levels | 59 |
statistical significance | 59 |
receptor binding | 59 |
total rna | 58 |
analyzed using | 58 |
stem cells | 58 |
polymerase chain | 57 |
cell surface | 57 |
disease severity | 57 |
gastroenteritis virus | 57 |
chain reaction | 56 |
bovine serum | 56 |
metabolic syndrome | 56 |
tagged ms | 56 |
sars coronavirus | 56 |
like receptor | 56 |
bat species | 56 |
cell epitopes | 56 |
binding affinity | 56 |
ventilator dependence | 56 |
hospital mortality | 55 |
infectious period | 55 |
nucleic acids | 55 |
antiviral activity | 55 |
differentially expressed | 55 |
respiratory disease | 54 |
important role | 54 |
saudi arabia | 54 |
life technologies | 54 |
active site | 54 |
ag cur | 54 |
genome sequences | 54 |
con con | 54 |
determined using | 53 |
stranded rna | 53 |
creat iveco | 53 |
licen ses | 53 |
viral infections | 53 |
intensive care | 53 |
org licen | 53 |
western blotting | 53 |
infectious bronchitis | 53 |
information accompanies | 53 |
coronavirus infection | 53 |
rabbit anti | 53 |
highly pathogenic | 53 |
iveco mmons | 53 |
pandemic influenza | 53 |
getv macro | 52 |
body weight | 52 |
class i | 52 |
respiratory viruses | 52 |
well plates | 52 |
dromedary camels | 51 |
lower respiratory | 51 |
immunodeficiency virus | 51 |
binding domain | 51 |
olive flounder | 51 |
viral clearance | 51 |
may also | 51 |
see supplementary | 51 |
lung cancer | 51 |
fever virus | 50 |
analysis using | 50 |
particle size | 50 |
circuit pressure | 50 |
sars fp | 50 |
human immunodeficiency | 50 |
analysis showed | 50 |
fold change | 50 |
virus infections | 49 |
wild type | 49 |
first time | 49 |
cell epitope | 49 |
plasma samples | 49 |
gum arabic | 49 |
antibody titers | 49 |
chikungunya virus | 49 |
rna binding | 49 |
clinical features | 48 |
determine whether | 48 |
genome sequencing | 48 |
reproduction number | 48 |
blood samples | 48 |
mass spectrometry | 48 |
human coronavirus | 48 |
bat paramyxovirus | 48 |
viral proteins | 48 |
signaling pathway | 48 |
disease control | 48 |
pseudotyped virus | 47 |
measured using | 47 |
spike glycoprotein | 47 |
rsv infection | 47 |
positive control | 47 |
virus disease | 47 |
endothelial cells | 47 |
treated cells | 47 |
time rt | 47 |
immune cells | 46 |
significantly reduced | 46 |
genome sequence | 46 |
human parainfluenza | 46 |
air conditioning | 46 |
infectious disease | 46 |
poly i | 46 |
pg ml | 46 |
antibody responses | 46 |
rna replication | 46 |
samples collected | 46 |
south korea | 46 |
two different | 46 |
rna virus | 45 |
breast cancer | 45 |
serum levels | 45 |
acute lung | 45 |
molecular dynamics | 45 |
differential expression | 45 |
high levels | 45 |
infected patients | 45 |
vesicular stomatitis | 45 |
also observed | 45 |
cell proliferation | 45 |
closely related | 45 |
social media | 45 |
kshv infection | 44 |
secondary antibody | 44 |
gp pseudotyped | 44 |
binding sites | 44 |
way anova | 44 |
total number | 44 |
mm nacl | 44 |
animal models | 44 |
viral genome | 44 |
results indicate | 44 |
large number | 44 |
innate immunity | 43 |
signaling pathways | 43 |
cells treated | 43 |
study design | 43 |
cell death | 43 |
final concentration | 43 |
statistical analyses | 43 |
respiratory failure | 43 |
well plate | 43 |
mm tris | 43 |
fruit bats | 43 |
inflammatory response | 43 |
like particles | 43 |
specific antibodies | 42 |
cb infected | 42 |
tract infections | 42 |
viral particles | 42 |
genomic dna | 42 |
lysis buffer | 42 |
also found | 42 |
cell migration | 42 |
sialic acid | 42 |
washed three | 42 |
influenza infection | 42 |
promoter activity | 42 |
epithelial cell | 42 |
fruit bat | 42 |
upper respiratory | 41 |
protective efficacy | 41 |
epitope prediction | 41 |
peripheral blood | 41 |
target genes | 41 |
cell viability | 41 |
recombinant protein | 41 |
blood pressure | 41 |
stomatitis virus | 41 |
bronchitis virus | 41 |
phylogenetic tree | 41 |
host cells | 41 |
cell responses | 41 |
relative humidity | 41 |
applied biosystems | 41 |
cohort study | 41 |
meo ma | 40 |
mononuclear cells | 40 |
th week | 40 |
subunit vaccine | 40 |
calculated using | 40 |
basic reproduction | 40 |
growth factor | 40 |
world health | 40 |
ms ms | 40 |
thermo scientific | 40 |
complete genome | 40 |
health organization | 39 |
vero cells | 39 |
fusion peptides | 39 |
real time | 39 |
helicobacter pylori | 39 |
hot spot | 39 |
cysvac advax | 39 |
tissue samples | 39 |
sars ifp | 39 |
clinical trials | 39 |
host species | 39 |
independent experiments | 39 |
flow rate | 39 |
rna polymerase | 39 |
heavy chain | 39 |
human transmission | 39 |
previous reports | 39 |
ethics committee | 39 |
virulent ibv | 39 |
binding protein | 39 |
septic shock | 39 |
feature selection | 39 |
tissue culture | 39 |
fluorescence intensity | 39 |
head group | 39 |
advax cpg | 39 |
quiescent stem | 38 |
neutrophil extracellular | 38 |
i interferon | 38 |
cytokine storm | 38 |
mrna expression | 38 |
severe covid | 38 |
corresponding author | 38 |
generation sequencing | 38 |
marburg virus | 38 |
hospitalized patients | 38 |
three different | 38 |
time point | 37 |
seasonal influenza | 37 |
reference gene | 37 |
even though | 37 |
coronavirus spike | 37 |
cov spike | 37 |
fatty acid | 37 |
virus entry | 37 |
control mice | 37 |
serially diluted | 37 |
culture medium | 37 |
viral loads | 37 |
domain iv | 37 |
molecular weight | 37 |
ge healthcare | 36 |
chimeric multiepitope | 36 |
infectious virus | 36 |
evaluated using | 36 |
isothermal amplification | 36 |
recent years | 36 |
dipeptidyl peptidase | 36 |
whole blood | 36 |
leaf blight | 36 |
recent study | 36 |
expression analysis | 36 |
viral protein | 36 |
positive cells | 36 |
lung tissue | 36 |
protease inhibitor | 36 |
nsp protease | 36 |
severe pneumonia | 36 |
graphpad prism | 36 |
virus glycoprotein | 36 |
results show | 35 |
sequence analysis | 35 |
tca cycle | 35 |
inflammatory cells | 35 |
antibody response | 35 |
dependent manner | 35 |
san diego | 35 |
cell types | 35 |
future studies | 35 |
cells expressing | 35 |
regression analysis | 35 |
reactive arthritis | 35 |
recent studies | 35 |
induced lung | 35 |
see table | 35 |
chest ct | 35 |
risk factor | 35 |
chikv nsp | 35 |
sample collection | 35 |
size distribution | 35 |
analysis revealed | 35 |
pdb id | 35 |
growth rate | 35 |
membrane protein | 35 |
human monoclonal | 35 |
standard curve | 35 |
buffered saline | 35 |
three independent | 34 |
intestinal epithelial | 34 |
risk score | 34 |
high level | 34 |
quantitative real | 34 |
host immune | 34 |
extracellular dna | 34 |
significantly different | 34 |
confirmed cases | 34 |
specific vhh | 34 |
infected animals | 34 |
structural proteins | 34 |
lateral flow | 34 |
oxidative stress | 34 |
mortality rates | 34 |
severe influenza | 34 |
mycobacterium tuberculosis | 34 |
drug delivery | 34 |
genetic diversity | 34 |
higher levels | 34 |
mers coronavirus | 34 |
congo hemorrhagic | 34 |
maximum likelihood | 34 |
cd cells | 34 |
delay propagation | 34 |
cell cultures | 34 |
molecular epidemiology | 34 |
igg antibody | 34 |
vaccine candidate | 34 |
life cycle | 34 |
fusion peptide | 33 |
post infection | 33 |
secondary structure | 33 |
sierra leone | 33 |
significantly decreased | 33 |
mrna levels | 33 |
converting enzyme | 33 |
serial dilutions | 33 |
analyte igg | 33 |
lymph nodes | 33 |
widely used | 33 |
transcription factor | 33 |
acute gastroenteritis | 33 |
clinical samples | 33 |
mice subjected | 33 |
polarization transfer | 33 |
protein kinase | 33 |
gastrointestinal symptoms | 32 |
hong kong | 32 |
mini kit | 32 |
mammalian cells | 32 |
social distancing | 32 |
adaptive immune | 32 |
mouse anti | 32 |
viral entry | 32 |
environmental factors | 32 |
factors associated | 32 |
nucleotide sequence | 32 |
age groups | 32 |
cell entry | 32 |
results indicated | 32 |
culture supernatant | 32 |
incubation period | 32 |
protein dimer | 32 |
lamina propria | 32 |
data suggest | 32 |
reasonable request | 32 |
treated mice | 32 |
chagas disease | 32 |
hli model | 32 |
erythrocyte invasion | 31 |
igg antibodies | 31 |
positive samples | 31 |
patients infected | 31 |
mice treated | 31 |
virus particles | 31 |
abasic pna | 31 |
generated using | 31 |
protective immunity | 31 |
apobec proteins | 31 |
rabbit igg | 31 |
sequence alignment | 31 |
nucleocapsid protein | 31 |
expressing codon | 31 |
mediated isothermal | 31 |
jamaican fruit | 31 |
protein sequences | 31 |
time series | 31 |
rna extraction | 31 |
clinical data | 31 |
ptm buffer | 31 |
pcr assay | 31 |
lung tissues | 31 |
luciferase activity | 31 |
day post | 31 |
dna vaccine | 31 |
care unit | 31 |
single nucleotide | 31 |
highly conserved | 31 |
assessed using | 31 |
cancer cell | 31 |
network analysis | 31 |
mdck cells | 31 |
gene segments | 31 |
dna constructs | 30 |
antibacterial activity | 30 |
commonly used | 30 |
reverse transcriptase | 30 |
santa cruz | 30 |
pcr using | 30 |
inhibitory effect | 30 |
human influenza | 30 |
chickens immunized | 30 |
equine antisera | 30 |
specific antibody | 30 |
financial interests | 30 |
relevant guidelines | 30 |
smoking cessation | 30 |
free energy | 30 |
lipid bilayers | 30 |
genbank accession | 30 |
mm hepes | 30 |
ibv strain | 30 |
extracellular traps | 30 |
nucleotide sequences | 30 |
light chain | 30 |
suppressor activity | 30 |
tgev infection | 30 |
elderly patients | 30 |
age distribution | 30 |
gel electrophoresis | 30 |
rhesus macaques | 30 |
transmission electron | 30 |
insulin resistance | 30 |
critically ill | 30 |
accession numbers | 30 |
early stage | 30 |
ebola entry | 30 |
human genome | 30 |
mainland china | 30 |
plaque assay | 30 |
confidence intervals | 30 |
cell lysates | 30 |
transmission dynamics | 29 |
cov rbd | 29 |
different concentrations | 29 |
fusion protein | 29 |
human infections | 29 |
plasma levels | 29 |
mdp values | 29 |
primary antibody | 29 |
cfu ml | 29 |
pathogenic avian | 29 |
strain mass | 29 |
specific igg | 29 |
paralichthys olivaceus | 29 |
porcine kobuvirus | 29 |
based assay | 29 |
tested positive | 29 |
pediatric patients | 29 |
wide range | 29 |
sequencing data | 29 |
rheumatoid arthritis | 29 |
survivor group | 29 |
pcr products | 29 |
acid sequences | 29 |
agarose gel | 29 |
previously published | 29 |
free water | 29 |
protein tag | 29 |
mice compared | 29 |
nervous system | 29 |
acid sequence | 28 |
experimental conditions | 28 |
regression model | 28 |
hours post | 28 |
quantitative pcr | 28 |
copy number | 28 |
findings suggest | 28 |
west africa | 28 |
diarrhoea seasonality | 28 |
also performed | 28 |
animal model | 28 |
immune activation | 28 |
animal care | 28 |
ill patients | 28 |
adenovirus type | 28 |
tlr expression | 28 |
lamp assay | 28 |
acid residues | 28 |
ibv vaccine | 28 |
gi disease | 28 |
purified using | 28 |
disease progression | 28 |
competing financial | 28 |
specific primers | 28 |
clinical outcome | 28 |
expressed genes | 28 |
indirubin derivatives | 28 |
clinical outcomes | 28 |
severe cases | 28 |
least one | 28 |
expression level | 28 |
respiratory infections | 28 |
mouth disease | 28 |
crispr cas | 28 |
white matter | 27 |
control measures | 27 |
rabies virus | 27 |
reactive protein | 27 |
high affinity | 27 |
mouse igg | 27 |
cytokine production | 27 |
pseudotyped hiv | 27 |
conjugated go | 27 |
case definitions | 27 |
marker genes | 27 |
kindly provided | 27 |
nasal turbinates | 27 |
severe disease | 27 |
clinical course | 27 |
polyclonal anti | 27 |
also showed | 27 |
whole genome | 27 |
skeletal muscle | 27 |
zikv challenge | 27 |
situation report | 27 |
detected using | 27 |
bl mice | 27 |
clinical symptoms | 27 |
hydrogen bonds | 27 |
ct values | 27 |
hepatocellular carcinoma | 27 |
molecular mechanisms | 27 |
colon epithelial | 27 |
protein levels | 27 |
surveillance system | 27 |
investigate whether | 27 |
impedance tomography | 27 |
ct score | 27 |
time reverse | 27 |
correlation coefficient | 27 |
organ dysfunction | 27 |
kg day | 27 |
rnai suppressor | 27 |
inflammatory cytokine | 26 |
target cells | 26 |
alexa fluor | 26 |
mhc class | 26 |
retrospective study | 26 |
vaccine construct | 26 |
evolutionary genetics | 26 |
datasets generated | 26 |
syndromic surveillance | 26 |
swab samples | 26 |
host range | 26 |
infected individuals | 26 |
quantified using | 26 |
virus titers | 26 |
rna structure | 26 |
critical role | 26 |
pcr amplification | 26 |
monoclonal anti | 26 |
hpiv species | 26 |
healthy controls | 26 |
wind speed | 26 |
sequence data | 26 |
contact tracing | 26 |
virus shedding | 26 |
ns protein | 26 |
tumor growth | 26 |
categorical variables | 26 |
per ml | 26 |
extracted using | 26 |
necrosis factor | 26 |
least stable | 26 |
blood cell | 26 |
influenza vaccine | 26 |
phage display | 26 |
chain version | 26 |
live ebov | 26 |
control groups | 26 |
human infection | 25 |
binding activity | 25 |
data indicate | 25 |
enzyme activity | 25 |
i ifn | 25 |
conventional method | 25 |
pcr analysis | 25 |
clinical trial | 25 |
electrical impedance | 25 |
newcastle disease | 25 |
silver nanoparticles | 25 |
tgev strains | 25 |
sample preparation | 25 |
increased expression | 25 |
human cells | 25 |
human adenovirus | 25 |
nlrp inflammasome | 25 |
univariate analysis | 25 |
body temperature | 25 |
water molecules | 25 |
cell cycle | 25 |
fetal bovine | 25 |
ml penicillin | 25 |
transfected cells | 25 |
influenza pneumonia | 25 |
ifnl mrna | 25 |
randomly selected | 25 |
virus rna | 25 |
open reading | 25 |
cell lysate | 25 |
ion torrent | 25 |
study period | 25 |
sanger sequencing | 25 |
iga responses | 25 |
per group | 25 |
ct value | 25 |
indirect elisa | 25 |
antibody levels | 25 |
airway epithelial | 25 |
phylogenetic analyses | 24 |
review board | 24 |
ileum epithelial | 24 |
endoplasmic reticulum | 24 |
structural basis | 24 |
respiratory infection | 24 |
bat rva | 24 |
conjugated goat | 24 |
rabbit haemorrhagic | 24 |
host defense | 24 |
viral titers | 24 |
bat guano | 24 |
cell marker | 24 |
lasv gp | 24 |
mm edta | 24 |
mouse monoclonal | 24 |
irradiation chamber | 24 |
clinical practice | 24 |
pcr system | 24 |
optofluidic platform | 24 |
insulin signaling | 24 |
negative controls | 24 |
pbs containing | 24 |
virus antigen | 24 |
dilution factor | 24 |
study showed | 24 |
obtained using | 24 |
viral nucleic | 24 |
national institute | 24 |
accession number | 24 |
secondary antibodies | 24 |
rna sequences | 24 |
may represent | 24 |
continuous variables | 24 |
resting eeg | 24 |
airborne iav | 24 |
anthelmintic drugs | 24 |
gene sequences | 24 |
recombination event | 24 |
data set | 24 |
central nervous | 24 |
protein interactions | 24 |
immunofluorescence assay | 24 |
alphavirus nsp | 24 |
corticosteroid use | 24 |
reading frames | 24 |
nervous necrosis | 24 |
supplementary tables | 24 |
mice infected | 24 |
biv pacing | 24 |
disease transmission | 24 |
dna polymerase | 24 |
haemorrhagic disease | 24 |
cb infection | 24 |
venom proteins | 24 |
institutional review | 24 |
cells infected | 23 |
tcid ml | 23 |
optimization problem | 23 |
significant increase | 23 |
optimal control | 23 |
lung inflammation | 23 |
luciferase reporter | 23 |
better understand | 23 |
pfu ml | 23 |
among children | 23 |
human respiratory | 23 |
negatively charged | 23 |
strains isolated | 23 |
hfmd patients | 23 |
small intestine | 23 |
type ii | 23 |
reading frame | 23 |
medical center | 23 |
bacterial gastroenteritis | 23 |
hybrid nps | 23 |
limited number | 23 |
activated protein | 23 |
previous report | 23 |
recombination events | 23 |
nonhuman primates | 23 |
deep learning | 23 |
respiratory pathogens | 23 |
pna probes | 23 |
extracellular matrix | 23 |
viet nam | 23 |
culture supernatants | 23 |
increased risk | 23 |
hav ig | 23 |
regression analyses | 23 |
nitric oxide | 23 |
capsid protein | 23 |
transmembrane domain | 23 |
bd biosciences | 23 |
spatially structured | 23 |
considered statistically | 23 |
structural protein | 23 |
shear stress | 23 |
curve analysis | 23 |
pbs buffer | 23 |
pdm infection | 23 |
animal experiments | 23 |
scanning electron | 23 |
authors reviewed | 23 |
copies per | 23 |
two viruses | 23 |
data sets | 23 |
aerosol method | 23 |
national institutes | 23 |
magnetic field | 23 |
femoral artery | 23 |
mg dl | 23 |
human health | 23 |
correlation coefficients | 23 |
fatality rate | 23 |
may lead | 23 |
significant reduction | 23 |
organ failure | 22 |
cell count | 22 |
bone marrow | 22 |
pdm mice | 22 |
tm ct | 22 |
inhibitory activity | 22 |
cells using | 22 |
aerosol samples | 22 |
control seasonal | 22 |
confidence interval | 22 |
adult patients | 22 |
necrosis virus | 22 |
bacterial leaf | 22 |
side chain | 22 |
national health | 22 |
assay kit | 22 |
expression profile | 22 |
dependence risk | 22 |
viral pathogens | 22 |
neutralizing monoclonal | 22 |
supplementary material | 22 |
vaccine candidates | 22 |
likely due | 22 |
stable reference | 22 |
oxygen saturation | 22 |
virtual screening | 22 |
iav densities | 22 |
signal transduction | 22 |
homing receptors | 22 |
retinoic acid | 22 |
ml streptomycin | 22 |
ang ii | 22 |
membrane potential | 22 |
studies showed | 22 |
also used | 22 |
community detection | 22 |
ad libitum | 22 |
dimer containing | 22 |
lung function | 22 |
ds patients | 22 |
plasma membrane | 22 |
protein structure | 22 |
pdm virus | 22 |
genomic rna | 22 |
proteomic analysis | 22 |
electron microscope | 22 |
tumor necrosis | 22 |
related genes | 22 |
specific antisera | 22 |
linked immunosorbent | 22 |
primary antibodies | 22 |
ifn signaling | 22 |
key role | 22 |
bacterial infections | 22 |
pulmonary disease | 22 |
replication competent | 22 |
first step | 22 |
virus transmission | 22 |
murine norovirus | 22 |
high degree | 22 |
human papillomavirus | 22 |
erythrocyte surface | 22 |
bacterial pathogens | 22 |
multiple sequence | 22 |
influenza surveillance | 22 |
whole region | 22 |
tb patients | 22 |
supplementary dataset | 22 |
protective antigen | 22 |
antiviral response | 22 |
per day | 22 |
phase i | 22 |
syndrome virus | 22 |
pcr product | 22 |
cell membrane | 22 |
dpp inhibitors | 22 |
machine learning | 22 |
target segment | 21 |
deficient mice | 21 |
linear regression | 21 |
conducted using | 21 |
significantly associated | 21 |
high risk | 21 |
polyclonal antibody | 21 |
interspecies transmission | 21 |
staphylococcus aureus | 21 |
porcine respiratory | 21 |
admission day | 21 |
epidemic diarrhoea | 21 |
age group | 21 |
th cells | 21 |
significance level | 21 |
neutralizing epitopes | 21 |
nucleotide positions | 21 |
coli lysate | 21 |
relatively small | 21 |
young children | 21 |
conjugated anti | 21 |
disease outbreaks | 21 |
road network | 21 |
nucleotide substitution | 21 |
uvc light | 21 |
thank dr | 21 |
method group | 21 |
library preparation | 21 |
recombinant viruses | 21 |
bhk cells | 21 |
absolute humidity | 21 |
cancer patients | 21 |
mrna translation | 21 |
air quality | 21 |
data showed | 21 |
may result | 21 |
least two | 21 |
per well | 21 |
tissue sections | 21 |
distilled water | 21 |
fusion proteins | 21 |
protein assay | 21 |
prediction model | 21 |
mean value | 21 |
serum albumin | 21 |
nuclear translocation | 21 |
using real | 21 |
clinical studies | 21 |
microwave power | 21 |
done using | 21 |
core protein | 21 |
population size | 21 |
post inoculation | 21 |
signal peptide | 21 |
chinese hamster | 21 |
assay using | 21 |
platelet count | 21 |
ebola infection | 21 |
vivo cultures | 21 |
ace ko | 21 |
nucleotide polymorphisms | 21 |
small number | 21 |
operating room | 21 |
positive patients | 21 |
distance matrix | 21 |
regulated genes | 21 |
clinical manifestations | 21 |
similar results | 21 |
science foundation | 21 |
delta inulin | 21 |
distal ribose | 21 |
several studies | 21 |
elderly group | 21 |
liquid chromatography | 21 |
model membranes | 21 |
ko mice | 21 |
chicken embryos | 21 |
reproductive number | 21 |
bacterial species | 21 |
expression system | 21 |
respiratory coronavirus | 20 |
null hypothesis | 20 |
biological processes | 20 |
autoimmune arthritis | 20 |
protein interaction | 20 |
proinflammatory cytokines | 20 |
neutralization assay | 20 |
cytopathic effect | 20 |
odds ratio | 20 |
freight trains | 20 |
time course | 20 |
endolysosomal calcium | 20 |
cell receptor | 20 |
proinflammatory cytokine | 20 |
niflumic acid | 20 |
standard deviations | 20 |
analysed using | 20 |
specific binding | 20 |
airborne microorganisms | 20 |
containing protein | 20 |
three days | 20 |
performed according | 20 |
polyacrylamide gel | 20 |
influenza incidence | 20 |
genome type | 20 |
west nile | 20 |
considered significant | 20 |
protease inhibitors | 20 |
image analysis | 20 |
signal intensity | 20 |
molecular evolutionary | 20 |
using two | 20 |
inflammatory responses | 20 |
receptor signaling | 20 |
pulmonary tuberculosis | 20 |
essential genes | 20 |
esrd patients | 20 |
endogenous control | 20 |
fold increase | 20 |
low levels | 20 |
infected livers | 20 |
pseudotyped viruses | 20 |
high mortality | 20 |
hz shx | 20 |
two weeks | 20 |
forward primer | 20 |
much higher | 20 |
pathway analysis | 20 |
expression studies | 20 |
dorsal horn | 20 |
expression data | 20 |
high expression | 20 |
thrombocytosis group | 20 |
transcriptome analysis | 20 |
median age | 20 |
ml niclosamide | 20 |
rna copies | 20 |
study demonstrated | 20 |
lymph node | 20 |
diabetes mellitus | 20 |
related patients | 20 |
high throughput | 20 |
host factors | 20 |
results obtained | 20 |
viral shedding | 20 |
malaria parasite | 20 |
spatial distribution | 20 |
batrachochytrium salamandrivorans | 20 |
encephalitis virus | 20 |
much lower | 20 |
also detected | 20 |
two days | 20 |
plasma sample | 20 |
individual differences | 20 |
molecular biology | 20 |
spinal cord | 20 |
new york | 20 |
ct images | 20 |
study also | 20 |
publicly available | 20 |
formic acid | 20 |
nodavirus antibody | 20 |
guinea pigs | 19 |
zikv infection | 19 |
nasal discharge | 19 |
bioaerosol sampling | 19 |
laboratory findings | 19 |
suckling piglets | 19 |
airborne influenza | 19 |
technical assistance | 19 |
virus infected | 19 |
cdna synthesis | 19 |
preterm infants | 19 |
reservoir hosts | 19 |
reported previously | 19 |
social network | 19 |
vascular endothelial | 19 |
interaction energy | 19 |
hydrophobic region | 19 |
sodium citrate | 19 |
cytokine levels | 19 |
test results | 19 |
hek cells | 19 |
time period | 19 |
higher number | 19 |
directed mutagenesis | 19 |
crystal structures | 19 |
red blood | 19 |
virus detection | 19 |
infective endocarditis | 19 |
virus binding | 19 |
dendritic cell | 19 |
use committee | 19 |
pcr primers | 19 |
study population | 19 |
results demonstrated | 19 |
population density | 19 |
hierarchical clustering | 19 |
based approach | 19 |
directional changes | 19 |
dpp expression | 19 |
vaccinia virus | 19 |
table shows | 19 |
force field | 19 |
conformational changes | 19 |
least three | 19 |
dna viruses | 19 |
citric acid | 19 |
confocal microscopy | 19 |
regulatory factor | 19 |
transmission rate | 19 |
iii iv | 19 |
transgenic mice | 19 |
years old | 19 |
virucidal effect | 19 |
approved drugs | 19 |
cov nucleocapsid | 19 |
immunosorbent assay | 19 |
salivary protein | 19 |
copies ml | 19 |
ari episodes | 19 |
cleavage site | 19 |
crucial role | 19 |
virus strains | 19 |
multiple sclerosis | 19 |
pneumonia patients | 19 |
written informed | 19 |
terminal region | 19 |
molecular basis | 19 |
virus neutralization | 19 |
macrophage activation | 19 |
novel human | 19 |
human erythrocytes | 19 |
urinary nephrin | 19 |
log fold | 19 |
cells well | 19 |
buffer containing | 19 |
next generation | 19 |
human movement | 19 |
using different | 19 |
gastric cancer | 18 |
power density | 18 |
may contribute | 18 |
future work | 18 |
body mass | 18 |
white blood | 18 |
protein concentration | 18 |
data interpretation | 18 |
egyptian fruit | 18 |
acid substitutions | 18 |
nile tilapia | 18 |
epidemic size | 18 |
card deficiency | 18 |
sp parasites | 18 |
experimental infection | 18 |
domain ii | 18 |
porcine reproductive | 18 |
sham controls | 18 |
government effectiveness | 18 |
protein sequence | 18 |
coronavirus hku | 18 |
binding motifs | 18 |
human plasma | 18 |
one hour | 18 |
disease outbreak | 18 |
energy metabolism | 18 |
spatial super | 18 |
sir model | 18 |
fecal nucleic | 18 |
human macrophages | 18 |
cell signaling | 18 |
transmembrane protein | 18 |
quantitative reverse | 18 |
vaccinated animals | 18 |
new coronavirus | 18 |
cell response | 18 |
central air | 18 |
exercise training | 18 |
strand rna | 18 |
patients admitted | 18 |
computed tomography | 18 |
ibv protection | 18 |
isolated individuals | 18 |
conserved among | 18 |
commercially available | 18 |
host response | 18 |
electric field | 18 |
iu ml | 18 |
dna damage | 18 |
false positive | 18 |
signal overlap | 18 |
uv light | 18 |
antibody fragments | 18 |
nasal spray | 18 |
bacterial blight | 18 |
induced apoptosis | 18 |
overlapping genes | 18 |
side effects | 18 |
fold higher | 18 |
ct scans | 18 |
rna synthesis | 18 |
collected data | 18 |
horseradish peroxidase | 18 |
surface area | 18 |
results demonstrate | 18 |
final volume | 18 |
lipid bilayer | 18 |
rotavirus strains | 18 |
calcium phosphate | 18 |
igg indirect | 18 |
insectivorous bats | 18 |
expression profiles | 18 |
three weeks | 18 |
early phase | 18 |
investigated whether | 18 |
resonant frequency | 18 |
common pipistrelle | 18 |
cell activation | 18 |
pfcrn expression | 18 |
showed significantly | 18 |
seir model | 18 |
rabbit polyclonal | 18 |
plasmid dna | 18 |
infected subjects | 18 |
coding sequences | 18 |
results suggested | 18 |
bacillus anthracis | 18 |
reference genome | 18 |
transmission routes | 18 |
ct scan | 18 |
protein synthesis | 18 |
donor pigs | 18 |
filovirus igg | 18 |
early stages | 18 |
sense rna | 18 |
wild birds | 18 |
healthy subjects | 18 |
functional analysis | 18 |
dynamics simulations | 18 |
induced arthritis | 18 |
dmem containing | 18 |
mm sodium | 18 |
respiratory illness | 18 |
upper airway | 17 |
southern china | 17 |
washed times | 17 |
vice versa | 17 |
blood cells | 17 |
may help | 17 |
biosafety level | 17 |
kidney disease | 17 |
likelihood method | 17 |
energy transfer | 17 |
target microorganisms | 17 |
antiviral activities | 17 |
expression vector | 17 |
using primers | 17 |
genomic sequences | 17 |
virus genomes | 17 |
ms analysis | 17 |
asthma exacerbation | 17 |
rbd binding | 17 |
human host | 17 |
essential role | 17 |
southeast asia | 17 |
virus ns | 17 |
inactivation ratio | 17 |
hcv infection | 17 |
new england | 17 |
dna replication | 17 |
blocking agents | 17 |
using graphpad | 17 |
disease spread | 17 |
positive correlation | 17 |
glutamic acid | 17 |
genetics analysis | 17 |
chicken eggs | 17 |
neutralisation assay | 17 |
falciparum malaria | 17 |
human mobility | 17 |
higher mortality | 17 |
tuberculosis infection | 17 |
viral genomes | 17 |
pm concentrations | 17 |
rva strains | 17 |
renilla luciferase | 17 |
geometric mean | 17 |
asthma seasonal | 17 |
chifit gene | 17 |
terminal domain | 17 |
direct contact | 17 |
sofa score | 17 |
survival rate | 17 |
hoc test | 17 |
symptom onset | 17 |
tumor cell | 17 |
natural reservoir | 17 |
time detection | 17 |
bone mineral | 17 |
incubated overnight | 17 |
antibody production | 17 |
also thank | 17 |
pseudotyped vsv | 17 |
ifit proteins | 17 |
corticosteroid treatment | 17 |
prion infection | 17 |
elongation complex | 17 |
comparative analysis | 17 |
rna interference | 17 |
validation cohort | 17 |
urine samples | 17 |
conditioning system | 17 |
medium containing | 17 |
cov fp | 17 |
possible role | 17 |
tandem repeats | 17 |
like domain | 17 |
web server | 17 |
inhibitor cocktail | 17 |
pfripr antibodies | 17 |
using anti | 17 |
cell debris | 17 |
confocal microscope | 17 |
drug discovery | 17 |
pfcrn gene | 17 |
normally distributed | 17 |
sybr green | 17 |
transmission events | 17 |
antigen presentation | 17 |
fold serial | 17 |
luciferase assay | 17 |
coronavirus pneumonia | 17 |
bal fluid | 17 |
human igg | 17 |
log copies | 17 |
isg expression | 17 |
influenza hemagglutinin | 17 |
cruz biotechnology | 17 |
host shifts | 17 |
cell growth | 17 |
social behavior | 17 |
virus via | 17 |
gold nanoparticles | 17 |
dna sequences | 17 |
knockout mice | 17 |
emergency department | 17 |
genome copies | 17 |
infected groups | 17 |
hantavirus infection | 17 |
latent period | 17 |
infected cases | 17 |
fc receptor | 17 |
controlled trial | 17 |
final epidemic | 17 |
coding sequence | 17 |
antiviral drugs | 17 |
pcr assays | 17 |
obstructive pulmonary | 16 |
high dose | 16 |
neutralisation assays | 16 |
viral pneumonia | 16 |
ig titers | 16 |
different time | 16 |
future research | 16 |
pten overexpression | 16 |
virus titration | 16 |
random walk | 16 |
cytokine release | 16 |
bacterial growth | 16 |
virus neutralisation | 16 |
human subjects | 16 |
protein identification | 16 |
cytokine responses | 16 |
may provide | 16 |
nk cells | 16 |
new insights | 16 |
african genotype | 16 |
surface pm | 16 |
time periods | 16 |
cell differentiation | 16 |
bayesian inference | 16 |
wound healing | 16 |
virus titer | 16 |
public transportation | 16 |
detection kit | 16 |
genome types | 16 |
elisa plates | 16 |
rrna gene | 16 |
laser ablation | 16 |
acute phase | 16 |
medical research | 16 |
class ii | 16 |
previously shown | 16 |
higher level | 16 |
quantitative analysis | 16 |
vitro transcription | 16 |
vaccine design | 16 |
early detection | 16 |
lavage fluid | 16 |
housekeeping genes | 16 |
multiepitope vaccine | 16 |
human neutralizing | 16 |
rank test | 16 |
exact test | 16 |
antibody repertoire | 16 |
macro domains | 16 |
ionic strength | 16 |
ha protein | 16 |
liquid nitrogen | 16 |
ribosomal rna | 16 |
cell adhesion | 16 |
two distinct | 16 |
one day | 16 |
visualized using | 16 |
central role | 16 |
also significantly | 16 |
novel avian | 16 |
host proteins | 16 |
ms coat | 16 |
interferon regulatory | 16 |
drug targets | 16 |
three groups | 16 |
based vaccine | 16 |
case fatality | 16 |
alveolar macrophages | 16 |
location information | 16 |
standard error | 16 |
samples using | 16 |
retrospective cohort | 16 |
mbl gene | 16 |
mitochondria isolated | 16 |
variant tgev | 16 |
random effect | 16 |
promoter region | 16 |
endothelial growth | 16 |
heart disease | 16 |
super variable | 16 |
human antibody | 16 |
relatively low | 16 |
npc domain | 16 |
medical records | 16 |
software version | 16 |
zika igg | 16 |
severe patients | 16 |
chronic obstructive | 16 |
past infection | 16 |
broadly neutralizing | 16 |
cell pellets | 16 |
containing fbs | 16 |
proteins identified | 16 |
binding pocket | 16 |
clinically relevant | 16 |
virus protein | 16 |
highly expressed | 16 |
respiratory virus | 16 |
binding buffer | 16 |
hind limb | 16 |
graphpad software | 16 |
emerging infectious | 16 |
loaded onto | 16 |
probably due | 16 |
software package | 16 |
fecal samples | 16 |
related complications | 16 |
reverse genetics | 16 |
bacterial inoculum | 16 |
allowed us | 16 |
diagnostic sensitivity | 16 |
fluorescence microscopy | 16 |
npm protein | 16 |
enzymatic activity | 16 |
phylogenetic trees | 16 |
poor prognosis | 16 |
also known | 16 |
good agreement | 16 |
tumor cells | 16 |
polyclonal antibodies | 16 |
viral fusion | 16 |
reactive oxygen | 16 |
washed twice | 16 |
dipolar mode | 16 |
control strategies | 16 |
specific pathogen | 16 |
recombinant virus | 16 |
well known | 16 |
indoor air | 16 |
ebov neutralisation | 16 |
cholesterol accumulation | 16 |
clinical presentation | 16 |
recombinant proteins | 16 |
small sample | 16 |
three areas | 16 |
healthy individuals | 16 |
gene ontology | 15 |
identify genes | 15 |
conformational epitopes | 15 |
dna sequence | 15 |
cell membranes | 15 |
complex networks | 15 |
monte carlo | 15 |
highly correlated | 15 |
england biolabs | 15 |
hepg cells | 15 |
four hours | 15 |
activation syndrome | 15 |
heat shock | 15 |
free dmem | 15 |
copy numbers | 15 |
one week | 15 |
differential gene | 15 |
filovirus antigen | 15 |
individual samples | 15 |
tissue damage | 15 |
induced inflammation | 15 |
sequence identity | 15 |
human disease | 15 |
molecular docking | 15 |
simplex virus | 15 |
biological replicates | 15 |
inflammatory bowel | 15 |
term memory | 15 |
control samples | 15 |
specific cd | 15 |
fasting compared | 15 |
straight line | 15 |
surface plasmon | 15 |
enteric viruses | 15 |
ig products | 15 |
influenza strains | 15 |
physicochemical properties | 15 |
eye drop | 15 |
also tested | 15 |
abnormal elevation | 15 |
membrane curvature | 15 |
fold dilutions | 15 |
prolonged mechanical | 15 |
influenza cases | 15 |
molecular degree | 15 |
huh cells | 15 |
stat activation | 15 |
image processing | 15 |
hydrogen bond | 15 |
plasmon resonance | 15 |
landscape compatibility | 15 |
hcv rna | 15 |
magnetic resonance | 15 |
constructed using | 15 |
increased levels | 15 |
hiv gp | 15 |
gal receptors | 15 |
highly sensitive | 15 |
live attenuated | 15 |
antibody binding | 15 |
blood vessels | 15 |
negative results | 15 |
porcine rotavirus | 15 |
lung pathology | 15 |
infection control | 15 |
total protein | 15 |
discovery cohort | 15 |
roc curve | 15 |
peste des | 15 |
ion channel | 15 |
one study | 15 |
severe dengue | 15 |
throughput sequencing | 15 |
nile virus | 15 |
rna samples | 15 |
data generated | 15 |
bacterial communities | 15 |
cell type | 15 |
random effects | 15 |
significantly enriched | 15 |
better understanding | 15 |
protection experiment | 15 |
mm imidazole | 15 |
cell survival | 15 |
chronic kidney | 15 |
ace interaction | 15 |
asthmatic mice | 15 |
antiviral effect | 15 |
malaria parasites | 15 |
feline calicivirus | 15 |
risk areas | 15 |
aligned using | 15 |
disease surveillance | 15 |
highly contagious | 15 |
compared using | 15 |
among patients | 15 |
showed significant | 15 |
might also | 15 |
calf serum | 15 |
tested using | 15 |
cytoplasmic domain | 15 |
normal aging | 15 |
growth rates | 15 |
min pi | 15 |
molecular diagnostic | 15 |
ambient noise | 15 |
aerosol route | 15 |
relative risk | 15 |
exposed patients | 15 |
tract infection | 15 |
des petits | 15 |
observational study | 15 |
selected based | 15 |
gene symbols | 15 |
associated coronavirus | 15 |
sensitivity analysis | 15 |
rna using | 15 |
ibv challenge | 15 |
test number | 15 |
overall mdp | 15 |
codon usage | 15 |
ifit gene | 15 |
structural part | 15 |
aging process | 15 |
stimulated genes | 15 |
bowel disease | 15 |
statistical computing | 15 |
normal distribution | 15 |
health care | 15 |
climatic factors | 15 |
human mers | 15 |
general population | 15 |
pbs group | 15 |
environmental dna | 15 |
abdominal pain | 15 |
treatment group | 15 |
prosocial behavior | 15 |
reaction mixture | 15 |
four different | 15 |
au nps | 15 |
site residues | 15 |
pathogen infection | 15 |
immunized chickens | 15 |
antiviral therapy | 15 |
health commission | 15 |
related viruses | 15 |
method using | 15 |
pathogenic isolates | 15 |
empty vector | 15 |
enveloped viruses | 15 |
serological cross | 15 |
differences among | 15 |
platelet counts | 15 |
test whether | 15 |
mucosal immunity | 15 |
active tb | 15 |
intestinal tract | 15 |
large scale | 15 |
petits ruminants | 15 |
igg responses | 15 |
blood flow | 15 |
sgta ablation | 15 |
bat coronavirus | 15 |
full genome | 15 |
nanopore sequencing | 15 |
optical density | 15 |
bone formation | 15 |
cells cultured | 14 |
internal control | 14 |
natural science | 14 |
independent risk | 14 |
data bank | 14 |
first two | 14 |
rna detection | 14 |
ii iii | 14 |
marine predators | 14 |
like receptors | 14 |
responses induced | 14 |
like illness | 14 |
freight traffic | 14 |
northern italy | 14 |
ethics statement | 14 |
fixed paraffin | 14 |
gene family | 14 |
ra plus | 14 |
symptomatic infections | 14 |
dnase turbo | 14 |
size reduction | 14 |
coding region | 14 |
cold pbs | 14 |
first study | 14 |
higher expression | 14 |
pm concentration | 14 |
days later | 14 |
gel phase | 14 |
solution containing | 14 |
cardiac aes | 14 |
institutional animal | 14 |
niclosamide treatment | 14 |
incubation phase | 14 |
different species | 14 |
independent factors | 14 |
hcv replication | 14 |
diagnostic tests | 14 |
buffered formalin | 14 |
analysis reveals | 14 |
forest virus | 14 |
north american | 14 |
silico analysis | 14 |
severe sepsis | 14 |
culture plates | 14 |
without pards | 14 |
national natural | 14 |
merozoite invasion | 14 |
rna secondary | 14 |
stranded dna | 14 |
alveolar epithelial | 14 |
malaria vaccine | 14 |
aspartic acid | 14 |
acid pairs | 14 |
observational studies | 14 |
molecular mechanism | 14 |
blood group | 14 |
significant changes | 14 |
gel filtration | 14 |
using specific | 14 |
recently reported | 14 |
affinity selection | 14 |
two types | 14 |
sodium dodecyl | 14 |
conditional autoregression | 14 |
genetic variation | 14 |
prepared using | 14 |
surveillance data | 14 |
dromedary camel | 14 |
control genes | 14 |
genes involved | 14 |
transiently transfected | 14 |
spike gene | 14 |
pipistrelle bat | 14 |
binding lectin | 14 |
high resolution | 14 |
mice showed | 14 |
target gene | 14 |
limb ischemia | 14 |
rndvs expressing | 14 |
transcription polymerase | 14 |
hubei province | 14 |
virus isolation | 14 |
aptamer chimera | 14 |
stat phosphorylation | 14 |
dna binding | 14 |
herpes simplex | 14 |
rad laboratories | 14 |
significant correlation | 14 |
megena modules | 14 |
recognition receptors | 14 |
protein bands | 14 |
protein binding | 14 |
candidate reference | 14 |
physical dilution | 14 |
positively selected | 14 |
mechanical hyperalgesia | 14 |
low dose | 14 |
data obtained | 14 |
parameter estimation | 14 |
zika vrna | 14 |
essential medium | 14 |
antimicrobial activity | 14 |
temporal dynamics | 14 |
pilot study | 14 |
molar ratio | 14 |
peptide binding | 14 |
prv hnx | 14 |
gp spike | 14 |
reads mapping | 14 |
coronavirus associated | 14 |
bacterial phyla | 14 |
viral genomic | 14 |
batcov hku | 14 |
disease network | 14 |
included studies | 14 |
anthrax toxin | 14 |
gia activity | 14 |
patient samples | 14 |
murine irf | 14 |
indirect elisas | 14 |
log reduction | 14 |
protein family | 14 |
amplified using | 14 |
east asia | 14 |
pdm group | 14 |
dependent rna | 14 |
ifit genes | 14 |
ifitm proteins | 14 |
close proximity | 14 |
biological characteristics | 14 |
authors thank | 14 |
human ifit | 14 |
significantly inhibited | 14 |
antibody repertoires | 14 |
significantly less | 14 |
lps group | 14 |
heptad repeat | 14 |
infected population | 14 |
final manuscript | 14 |
dnase i | 14 |
two strains | 14 |
multivariate logistic | 14 |
species transmission | 14 |
dodecyl sulfate | 14 |
wuhan university | 14 |
spike proteins | 14 |
primary human | 14 |
based vaccines | 14 |
pulmonary inflammation | 14 |
ser ala | 14 |
significant association | 14 |
bronchoalveolar lavage | 14 |
data show | 14 |
infected hepatocytes | 14 |
primer sequences | 14 |
supplementary materials | 14 |
beckman coulter | 14 |
several limitations | 14 |
japanese encephalitis | 14 |
infection prevention | 14 |
forming units | 14 |
available data | 14 |
genetic analysis | 14 |
blocking buffer | 14 |
cell lung | 14 |
poultry companies | 14 |
mortality risk | 14 |
mers patients | 14 |
interaction term | 14 |
predictive value | 14 |
antihyperalgesic effect | 14 |
mortality among | 14 |
relative expression | 14 |
also demonstrated | 14 |
post hoc | 14 |
secretor status | 14 |
viral dilution | 14 |
high frequency | 14 |
infectious periods | 14 |
late stages | 14 |
examined whether | 14 |
ray images | 14 |
two independent | 14 |
using lipofectamine | 14 |
mk cells | 14 |
gse qnpbytap | 14 |
acquired pneumonia | 14 |
mfon patients | 14 |
influenza pandemic | 14 |
origin influenza | 14 |
molecular evolution | 14 |
spinal dorsal | 14 |
ethical committee | 14 |
incidence risk | 14 |
oxygen species | 14 |
mean values | 13 |
major role | 13 |
chicken ifit | 13 |
anthropic noise | 13 |
cells compared | 13 |
plate reader | 13 |
ectopic expression | 13 |
kidney injury | 13 |
positive results | 13 |
positive controls | 13 |
pseudomonas syringae | 13 |
plaque purification | 13 |
autoregression term | 13 |
ic values | 13 |
zoonotic viruses | 13 |
mem medium | 13 |
recombination analysis | 13 |
sequence similarity | 13 |
human norovirus | 13 |
elisa system | 13 |
lymphocyte subpopulations | 13 |
purification kit | 13 |
mirna expression | 13 |
decreasing trend | 13 |
lung epithelial | 13 |
reverse primer | 13 |
endosomal escape | 13 |
dimer interface | 13 |
neutralizing epitope | 13 |
aerosol particles | 13 |
high performance | 13 |
drug administration | 13 |
mineral density | 13 |
streptococcus agalactiae | 13 |
control cells | 13 |
supplementary figs | 13 |
inflammation biomarkers | 13 |
glycosylation sites | 13 |
road networks | 13 |
test trials | 13 |
bone resorption | 13 |
negative regulation | 13 |
assay system | 13 |
infected samples | 13 |
drug design | 13 |
strand synthesis | 13 |
mean age | 13 |
inclusion criteria | 13 |
influenza season | 13 |
study group | 13 |
cytokine expression | 13 |
climate factors | 13 |
mannheimia haemolytica | 13 |
haemorrhagic fever | 13 |
kj mol | 13 |
yellow fever | 13 |
side chains | 13 |
epitopes using | 13 |
also reported | 13 |
iav infection | 13 |
study clinical | 13 |
rna genome | 13 |
genomic sequence | 13 |
cynomolgus macaques | 13 |
developing solution | 13 |
cys ala | 13 |
md simulations | 13 |
component analysis | 13 |
month follow | 13 |
immunomodulatory activity | 13 |
mbp segment | 13 |
recombinant pfripr | 13 |
substitution rate | 13 |
icc staining | 13 |
viral titer | 13 |
syringae pv | 13 |
airborne transmission | 13 |
cas system | 13 |
discovery rate | 13 |
risk hpv | 13 |
cytoplasmic tail | 13 |
large numbers | 13 |
virus np | 13 |
sivelestat sodium | 13 |
reporting system | 13 |
expression pattern | 13 |
case series | 13 |
mutant viruses | 13 |
biphasic calcium | 13 |
cho cell | 13 |
per reaction | 13 |
virus core | 13 |
first days | 13 |
web search | 13 |
replication cycle | 13 |
publication bias | 13 |
data indicated | 13 |
study provides | 13 |
transition time | 13 |
immune cell | 13 |
chang gung | 13 |
signal amplification | 13 |
prcv strain | 13 |
positive fecal | 13 |
stimulating factor | 13 |
adaptive evolution | 13 |
multiplex pcr | 13 |
linear mixed | 13 |
subclinical infectiousness | 13 |
default parameters | 13 |
leaves inoculated | 13 |
clinical diagnosis | 13 |
acid metabolism | 13 |
false discovery | 13 |
nasal cavity | 13 |
tissue tropism | 13 |
paving pattern | 13 |
human receptor | 13 |
expression stability | 13 |
secreting cells | 13 |
deep sequencing | 13 |
full length | 13 |
neural networks | 13 |
aqueous solution | 13 |
host responses | 13 |
structured conditional | 13 |
final version | 13 |
old spf | 13 |
viral hemorrhagic | 13 |
newly discovered | 13 |
corticosteroid therapy | 13 |
dna sequencing | 13 |
puerto rico | 13 |
described elsewhere | 13 |
hospital stay | 13 |
macrophage colony | 13 |
fusion activity | 13 |
may play | 13 |
viral respiratory | 13 |
cytokine response | 13 |
infectious dose | 13 |
reversible exchange | 13 |
impact score | 13 |
human lung | 13 |
plasma pools | 13 |
infections among | 13 |
virus polymerase | 13 |
sublingual immunization | 13 |
achieved using | 13 |
prospective study | 13 |
respiratory viral | 13 |
microbe interactions | 13 |
phase ii | 13 |
membrane topology | 13 |
autoimmune diseases | 13 |
propensity score | 13 |
pulmonary tb | 13 |
deliciosa leaves | 13 |
natural hosts | 13 |
severe respiratory | 13 |
infect humans | 13 |
expressed proteins | 13 |
rapid detection | 13 |
kcal mol | 13 |
viral membrane | 13 |
elution buffer | 13 |
commercial live | 13 |
crude rubi | 13 |
pr hv | 13 |
sendai virus | 13 |
remains unclear | 13 |
human rotavirus | 13 |
ctl epitopes | 13 |
gene silencing | 13 |
ccid ml | 13 |
igg levels | 13 |
two additional | 13 |
raw data | 13 |
chicken embryo | 13 |
virus production | 13 |
left panel | 13 |
mucosal immune | 13 |
acute asthma | 13 |
genomic characterization | 13 |
made available | 13 |
regional differences | 13 |
pseudomonas aeruginosa | 13 |
fold changes | 13 |
small molecules | 13 |
transcription factors | 13 |
mineral oil | 13 |
structure determination | 13 |
imaging system | 13 |
tetratricopeptide repeat | 13 |
enhanced ppe | 13 |
high sensitivity | 13 |
human gene | 13 |
lower bound | 13 |
higher risk | 13 |
antiviral effects | 13 |
master mix | 13 |
aedes aegypti | 13 |
red cell | 13 |
xanthomonas oryzae | 13 |
indirect immunofluorescence | 13 |
plus tgev | 13 |
spot region | 13 |
square test | 13 |
regional ventilation | 12 |
worth noting | 12 |
human brain | 12 |
infection induces | 12 |
cancer progression | 12 |
renal failure | 12 |
possibly due | 12 |
weighted degree | 12 |
water ad | 12 |
tertiary structure | 12 |
genetic characterization | 12 |
subgroup analysis | 12 |
flow cytometric | 12 |
life sciences | 12 |
jackson immunoresearch | 12 |
extracellular trap | 12 |
diarrhoea virus | 12 |
nicotine administration | 12 |
experimental setup | 12 |
cardiac surgery | 12 |
el paso | 12 |
virus load | 12 |
maternal immune | 12 |
lower levels | 12 |
serum free | 12 |
wearable device | 12 |
electron spin | 12 |
study demonstrates | 12 |
predators algorithm | 12 |
transgenic chicken | 12 |
atomic resolution | 12 |
immunofluorescence staining | 12 |
mitochondrial dysfunction | 12 |
protocol cii | 12 |
sindbis virus | 12 |
methods used | 12 |
primary enterocytes | 12 |
carnivore rabv | 12 |
highly connected | 12 |
exported protein | 12 |
outbreak response | 12 |
also examined | 12 |
spleen tissues | 12 |
many studies | 12 |
family members | 12 |
passenger trains | 12 |
genes enriched | 12 |
five times | 12 |
two short | 12 |
human nasal | 12 |
studies will | 12 |
symptoms onset | 12 |
viral antigen | 12 |
mbp target | 12 |
shock protein | 12 |
epr spectra | 12 |
research council | 12 |
pmn migration | 12 |
may cause | 12 |
ifitm expression | 12 |
chagas panel | 12 |
virus vaccine | 12 |
dna methylation | 12 |
inspired oxygen | 12 |
outbreak detection | 12 |
long sharp | 12 |
ethical approval | 12 |
relatively high | 12 |
severity scores | 12 |
challenge virus | 12 |
bat sera | 12 |
detergent micelles | 12 |
showed high | 12 |
principal component | 12 |
urgent need | 12 |
map kinase | 12 |
total volume | 12 |
severe clinical | 12 |
dna fragments | 12 |
mice immunized | 12 |
salicylanilide anthelmintic | 12 |
news outlets | 12 |
conditioning systems | 12 |
data used | 12 |
viral envelope | 12 |
surface proteins | 12 |
also evaluated | 12 |
marine fish | 12 |
protein quantification | 12 |
gene usage | 12 |
suckling pigs | 12 |
protein data | 12 |
hcv clearance | 12 |
common among | 12 |
elevated co | 12 |
native pfripr | 12 |
pulsed laser | 12 |
pseudorabies virus | 12 |
batrachochytrium dendrobatidis | 12 |
live poultry | 12 |
specific iga | 12 |
trypanosoma cruzi | 12 |
immune evasion | 12 |
sequence diversity | 12 |
ct findings | 12 |
significant genes | 12 |
tracheal swab | 12 |
coronavirus infections | 12 |
small glutamine | 12 |
among age | 12 |
aerosolized viruses | 12 |
ebola gp | 12 |
viral sequences | 12 |
airway epithelium | 12 |
passenger traffic | 12 |
complete coding | 12 |
number gse | 12 |
multiple testing | 12 |
molecular probes | 12 |
treg cells | 12 |
ablated particles | 12 |
chikv replication | 12 |
i peak | 12 |
pulmonary infection | 12 |
severity score | 12 |
surface protein | 12 |
mechanisms underlying | 12 |
transcription start | 12 |
hemorrhagic shock | 12 |
peptidase iv | 12 |
quality control | 12 |
lethal dose | 12 |
first draft | 12 |
scoring system | 12 |
human activity | 12 |
uv exposure | 12 |
modelling study | 12 |
light scattering | 12 |
membrane dehydration | 12 |
virus infectivity | 12 |
gene transcription | 12 |
fluorescence microscope | 12 |
nhbe cells | 12 |
cd cd | 12 |
clinical disease | 12 |
ace blocking | 12 |
membrane proteins | 12 |
cell counting | 12 |
density lipoprotein | 12 |
dengue hemorrhagic | 12 |
putative hydrophobic | 12 |
odds ratios | 12 |
elementary school | 12 |
swine respiratory | 12 |
canada goose | 12 |
disease ratio | 12 |
early warning | 12 |
functional receptor | 12 |
opioid receptor | 12 |
positive rate | 12 |
translational modifications | 12 |
induced acute | 12 |
epidemiological data | 12 |
slightly higher | 12 |
barr virus | 12 |
multiple organ | 12 |
effect term | 12 |
data analyses | 12 |
pcr kit | 12 |
uninfected control | 12 |
cystic fibrosis | 12 |
first case | 12 |
pao fio | 12 |
may explain | 12 |
positively charged | 12 |
target cell | 12 |
field intensity | 12 |
mobile phase | 12 |
heart rate | 12 |
ut cells | 12 |
blood mononuclear | 12 |
cell counts | 12 |
spin labels | 12 |
packaging signals | 12 |
prosocial concern | 12 |
secondary structures | 12 |
different genotypes | 12 |
type hadv | 12 |
directional change | 12 |
methods section | 12 |
protein structures | 12 |
small cell | 12 |
stably expressing | 12 |
nested pcr | 12 |
niclosamide inhibits | 12 |
corona virus | 12 |
estrogen receptor | 12 |
specific motifs | 12 |
qpcr analysis | 12 |
allele mrna | 12 |
operating rooms | 12 |
sharp straight | 12 |
emerging viruses | 12 |
patients may | 12 |
systemic inflammation | 12 |
hcv genome | 12 |
olfactory information | 12 |
accessory proteins | 12 |
weeks old | 12 |
case report | 12 |
negative sense | 12 |
hcl ph | 12 |
spatiotemporal model | 12 |
mortality associated | 12 |
penton base | 12 |
associated protein | 12 |
hadv dna | 12 |
phosphate buffered | 12 |
plasma concentrations | 12 |
phase transition | 12 |
ir catalyst | 12 |
protective effect | 12 |
series analysis | 12 |
detection rate | 12 |
using three | 12 |
bubble bursting | 12 |
power transfer | 12 |
blood glucose | 12 |
studies reported | 12 |
blocking vaccine | 12 |
potent neutralization | 12 |
different types | 12 |
invasion phenotype | 12 |
laboratory animals | 12 |
pt strain | 12 |
epitope mapping | 12 |
influenza epidemics | 12 |
human enterovirus | 12 |
based detection | 12 |
current status | 12 |
oreochromis niloticus | 12 |
also present | 12 |
mammalian cell | 12 |
developing countries | 12 |
log ec | 12 |
data demonstrate | 12 |
lassa virus | 12 |
start site | 12 |
weighted distance | 12 |
adverse effects | 12 |
slightly different | 12 |
lung disease | 12 |
humoral immunity | 12 |
less severe | 12 |
study revealed | 12 |
pb mutants | 12 |
comparative elisa | 12 |
gastrocnemius muscle | 12 |
clinical use | 12 |
domain i | 12 |
inflammatory effects | 12 |
reporter plasmids | 12 |
protein concentrations | 12 |
reverse primers | 12 |
camel mers | 12 |
myeloid cells | 12 |
pore size | 12 |
analysis version | 12 |
cardiac output | 12 |
previously demonstrated | 12 |
systemic immune | 12 |
receptor dpp | 12 |
lesser extent | 12 |
vaccinated mice | 12 |
disulfide bonds | 12 |
bronchial asthma | 12 |
nucleosome assembly | 12 |
immune mediators | 12 |
tumor suppressor | 11 |
cd expression | 11 |
strong positive | 11 |
patient tnbc | 11 |
body fluids | 11 |
dnase treatment | 11 |
go terms | 11 |
main operating | 11 |
rneasy mini | 11 |
pearson correlation | 11 |
missing data | 11 |
mass spectrometer | 11 |
infected pneumonia | 11 |
nerve ligation | 11 |
first wave | 11 |
virus strain | 11 |
novo assembly | 11 |
penicillin streptomycin | 11 |
air pollution | 11 |
test zone | 11 |
bronchial epithelial | 11 |
cell infiltration | 11 |
povidone iodine | 11 |
induced cell | 11 |
dna rna | 11 |
evolutionary relationship | 11 |
latin american | 11 |
stress response | 11 |
protease domain | 11 |
mice undergoing | 11 |
common ancestor | 11 |
shell decomposition | 11 |
control sample | 11 |
chain monte | 11 |
significantly improved | 11 |
like protease | 11 |
comparative study | 11 |
per mouse | 11 |
remains unknown | 11 |
model showed | 11 |
ophthalmia neonatorum | 11 |
rotavirus genotypes | 11 |
pedv spike | 11 |
fl signals | 11 |
tissue engineering | 11 |
per sample | 11 |
transfection reagent | 11 |
immunogenic proteins | 11 |
inflammatory drugs | 11 |
highly immunogenic | 11 |
highly virulent | 11 |
open public | 11 |
significantly altered | 11 |
diagnostic test | 11 |
discharged patients | 11 |
panel viruses | 11 |
community cohort | 11 |
haplotype pairs | 11 |
rectal swabs | 11 |
midwest city | 11 |
campylobacter jejuni | 11 |
among regions | 11 |
coronavirus replication | 11 |
unstructured random | 11 |
fluorescence quenching | 11 |
fmdv rna | 11 |
transferred onto | 11 |
higher oligomer | 11 |
spf chicken | 11 |
respiratory symptoms | 11 |